Proposal for individualized dosing of eculizumab in atypical hemolytic uremic syndrome: patient friendly and cost-effective.

Mendy Ter AvestRomy N BouwmeesterCaroline DuineveldKioa L WijnsmaElena B VolokhinaLambertus P W J van den HeuvelDavid M BurgerJack F M WetzelsNicole C A J van de KarRob Ter Heinenull null

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)

A patient-friendly individualized dosing strategy of eculizumab has the potential to improve treatment response at reduced costs.

Keyphrases

case report
low cost

risk assessment

human health

climate change